Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
42
# OF OVERLAPPING
HOLDINGS
VHT
428
HOLDINGS
11%
ALSO IN CANC
CANC
56
HOLDINGS
78%
ALSO IN VHT
SECTOR DRIFT (VHT minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.9% | 5.3% | 5.3% |
|
ABBVIE INC | 6.6% | 3.8% | 3.8% |
|
MERCK & CO. INC. | 4.7% | 3.6% | 3.6% |
|
JOHNSON & JOHNSON | 9.1% | 3.4% | 3.4% |
|
AMGEN INC | 2.9% | 2.6% | 2.6% |
VHT Overweight Relative to CANC
|
ELI LILLY & CO | 8.6% |
|
JOHNSON & JOHNSON | 5.7% |
|
UNITEDHEALTH GROUP INC | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
ABBVIE INC | 2.9% |
|
ABBOTT LABORATORIES | 2.6% |
|
PFIZER INC | 2.0% |
|
CVS CAREMARK CORP | 2.0% |
|
DANAHER CORP | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
VHT Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.6% |
|
COGENT BIOSCIENCES INC | -4.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
NOVARTIS AG | -4.0% |
 |
ASTRAZENECA PLC | -2.7% |
|
IMMUNOME, INC. | -2.7% |
 |
GENMAB A/S SPONSORED ADR | -2.6% |
|
CG ONCOLOGY, INC. | -2.6% |
|
EXELIXIS INC | -2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.5% |